Welcome to our dedicated page for Cutera news (Ticker: CUTR), a resource for investors and traders seeking the latest updates and insights on Cutera stock.
The CUTR news page on Stock Titan aggregates historical and restructuring-related news for Cutera, Inc., a company focused on aesthetic and dermatology solutions within the surgical and medical instrument manufacturing sector. Company releases describe Cutera as a provider of energy-based medical aesthetic technologies for practitioners worldwide, with more than 25 years of activity in the medical aesthetics field.
News coverage for CUTR includes financial performance updates, such as quarterly results that break out product and service revenue, trends in capital systems sales, recurring revenue, and cash balances. These reports also describe cost restructuring programs, non-GAAP financial measures, and changes in operating expenses, offering insight into how the business has managed its cost structure and profitability goals over time.
Another major category of news involves capital structure and corporate transformation. In 2025, Cutera announced a pre-packaged Chapter 11 restructuring supported by existing lenders, with plans to reduce debt and raise new financing. Subsequent releases detailed its intention to voluntarily delist its common stock from the Nasdaq Global Select Market, suspend SEC reporting obligations through a planned Form 15 filing, and ultimately emerge from Chapter 11 as a private company backed by a consortium of investment firms.
Product and partnership announcements also appear in the CUTR news flow. Examples include updates on AviClear, described as a breakthrough technology for acne treatment, and truFlex® muscle stimulation, as well as an exclusive distribution agreement through Cutera KK to promote and distribute select SkinCeuticals® products to medical and physician-led clinics in Japan. Cutera has also highlighted collaborations such as its partnership with the Adaptive Training Foundation to provide truFlex treatments to adaptive athletes.
By reviewing the CUTR news archive, users can trace how Cutera communicated its business performance, product developments, partnerships, restructuring steps, and transition from a publicly traded company to a privately held entity. This makes the news page a useful resource for understanding the company’s historical trajectory and the events that shaped its capital structure and market presence.
Cutera, Inc. (NASDAQ: CUTR) reported strong financial results for Q3 2021, with revenue of $57.4 million, a 47% increase year-over-year. Key growth drivers included capital equipment revenue of $32.2 million (up 33%) and recurring revenue of $25.2 million (up 68%). Notably, skincare revenue rose 117% to $14.8 million. Gross margin improved to 58.2%. Although the company experienced a net loss of $1.4 million, Adjusted EBITDA more than doubled to $5.1 million. Based on Q3 performance, Cutera raised its full-year revenue guidance to $224-$228 million.
Cutera, Inc. (CUTR) will report its third-quarter financial results on November 3, 2021, after market close. Management will host a conference call at 1:30 p.m. PT to discuss the results. Interested parties can join by dialing 1-877-705-6003 domestically or +1-201-493-6725 internationally, referencing Conference ID 13723851. The call will also be available via webcast on Cutera’s website, with a replay accessible approximately one hour post-call.
Cutera, Inc. (NASDAQ: CUTR), a provider of laser and energy-based aesthetic systems, announced that CEO Dave Mowry will participate in a virtual fireside chat at the Cantor Fitzgerald Global Healthcare Conference. The event is scheduled for 1:20 p.m. ET on Tuesday, September 28, 2021. A live webcast will be available in the Investors section of Cutera's website and will also be accessible for replay post-event. Cutera has been developing innovative products since 1998, supporting practitioners in providing safe aesthetic treatments.
Cutera, Inc. (NASDAQ: CUTR) reported a strong financial performance for Q2 2021, with revenues of $58.6 million, a 122% increase year-over-year. Key segments included capital equipment revenue of $35.6 million (up 129%) and recurring revenue of $23.0 million (up 113%). Gross margin improved to 57.7%, a 13.6-point increase. Adjusted EBITDA rose to $6.8 million from a loss of $3.5 million last year. For 2021, Cutera projects revenue between $215 million and $221 million, reflecting a 46% to 50% increase over 2020.
Summary not available.
Cutera, Inc. (Nasdaq: CUTR) announced it will report its second quarter 2021 financial results on August 4, 2021, after market close. Management will discuss these results in a conference call at 1:30 p.m. PT (4:30 p.m. ET) on the same day. Participants can join by calling 1-877-705-6003 (domestic) or +1-201-493-6725 (international), using Conference ID: 13721584. The call will also be accessible via a webcast on Cutera's Investor Relations website.
Cutera, Inc. (NASDAQ: CUTR) has renewed its exclusive distribution agreement with ZO Skin Health for skincare products in Japan, effective June 15, 2021, for an initial term of three years. This partnership aims to enhance the ZO skincare business while expanding Cutera's market presence in Japan. CEO Dave Mowry expressed satisfaction with the continued collaboration, emphasizing mutual growth opportunities over the next several years.
Cutera has appointed Sheila Hopkins to its Board of Directors, effective immediately. Chairman J. Daniel Plants praised her strategic capabilities, essential for Cutera's growth phase. CEO Dave Mowry expressed optimism about her commercial experience, beneficial for expanding Cutera's global operations. Hopkins has prior board experience and has held executive roles at Bausch + Lomb and Colgate-Palmolive. With her addition, Cutera aims to strengthen its position in the aesthetic systems market.
Cutera, a leader in energy-based aesthetic systems, will present at the Virtual UBS Global Healthcare Conference on May 26, 2021, at 3:00 pm ET. CEO Dave Mowry will lead the presentation, which will be available via webcast on the company's Investor Relations page. Based in Brisbane, California, Cutera has been providing innovative aesthetic solutions since 1998, enabling practitioners to deliver safe and effective treatments. For more details, visit www.cutera.com.
Cutera, Inc. (NASDAQ: CUTR) announces the resignation of President and COO Jason Richey, effective May 4, 2021, to pursue other opportunities. Richey will assist during the transition until May 31, 2021. CEO Dave Mowry will take on COO responsibilities temporarily. The company has engaged an executive search firm to find a new Chief Commercial Officer to steer growth. Both Mowry and Board Chairman J. Daniel Plants praised Richey's contributions during his tenure, highlighting his leadership during challenging times.